Skip to content

Maravai LifeSciences Holdings, Inc.

MRVI

CIK 0001823239

← back to feed
Revenue (TTM)
$201.71M
−28.3% YoY Q1 Mar 2026
Net Income (TTM)
−$98.83M
+9.7% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$0.68
+14.3% YoY Q1 Mar 2026
Gross Margin
39.3%
Q1 Mar 2026
Operating Margin
-78.6%
Q1 Mar 2026
Net Margin
-49.0%
Q1 Mar 2026
Free Cash Flow (TTM)
$53.41M
Q1 Mar 2026
Cash
$165.92M
Q1 Mar 2026
Total Debt
$241.01M
Q1 Mar 2026
Shares Outstanding
—
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings